EFFECT OF FLUVASTATIN ON LIPIDS AND FIBRINOLYSIS IN CORONARY-ARTERY DISEASE

Authors
BEVILACQUA M BETTICA P MILANI M VAGO T ROGOLINO A RIGHINI V SANTOLI E NORBIATO G
Citation
M. Bevilacqua et al., EFFECT OF FLUVASTATIN ON LIPIDS AND FIBRINOLYSIS IN CORONARY-ARTERY DISEASE, The American journal of cardiology, 79(1), 1997, pp. 84
Citations number
11
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
The American journal of cardiology → ACNP
ISSN journal
00029149
Volume
79
Issue
1
Year of publication
1997
Database
ISI
SICI code
0002-9149(1997)79:1<84:EOFOLA>2.0.ZU;2-G
Abstract
This randomized, double-blind, placebo-controlled study shows that 20- week fluvastatin treatment induces beneficial changes in the lipid pan el and a shift in the fibrinolytic pathway toward activation through a decrease in tissue plasminogen activator antigen. Fluvastatin treatme nt causes no variation in lipoprotein(a) circulating levels.